Published in J Biol Chem on January 25, 1982
Fast sequencing of oligosaccharides: the reagent-array analysis method. Proc Natl Acad Sci U S A (1992) 0.89
Purification to homogeneity of Charonia lampas alpha-fucosidase by using sequential ligand-affinity chromatography. Biochem J (1991) 0.84
Canine alpha-L-fucosidase in relation to the enzymic defect and storage products in canine fucosidosis. Biochem J (1988) 0.82
An alpha-L-fucosidase from Thermus sp. with unusually broad specificity. Glycoconj J (2001) 0.81
Antibody-affinity purification of novel alpha-L-fucosidase from mouse liver. Biochem J (1987) 0.78
Purification and characterization of alpha-L-fucosidase from human primary hepatocarcinoma tissue. World J Gastroenterol (2006) 0.77
Structure and substrate specificity of a eukaryotic fucosidase from Fusarium graminearum. J Biol Chem (2014) 0.77
Studies leading to the identification of ZD1839 (IRESSA): an orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor targeted to the treatment of cancer. Bioorg Med Chem Lett (2001) 2.86
Mammalian Notch1 is modified with two unusual forms of O-linked glycosylation found on epidermal growth factor-like modules. J Biol Chem (2000) 2.18
Vaginal cancer after maternal treatment with synthetic estrogens. N Engl J Med (1971) 2.07
Familial site-specific ovarian cancer is linked to BRCA1 on 17q12-21. Am J Hum Genet (1994) 1.71
Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium. Br J Cancer (2009) 1.54
Patterns of transcription in Bacillus subtilis during sporulation. J Mol Biol (1973) 1.49
Structural preferences of beta-galactoside-reactive lectins on Actinomyces viscosus T14V and Actinomyces naeslundii WVU45. Infect Immun (1983) 1.47
Somatic and germline mutations of the BRCA2 gene in sporadic ovarian cancer. Cancer Res (1996) 1.47
Beta-adrenoceptor stimulant properties of amidoalkylamino-substituted 1-aryl-2-ethanols and 1-(aryloxy)-2-propanols. J Med Chem (1981) 1.34
Pulmonary hypertrophic osteoarthropathy, spider angiomata, and estrogen hyperexcretion in neoplasia. Ann Intern Med (1969) 1.13
Monoclonal antibodies recognizing tumor-associated antigen of human ovarian mucinous cystadenocarcinomas. Cancer Res (1982) 1.12
O-glycan biosynthesis in human colorectal adenoma cells during progression to cancer. Eur J Biochem (1994) 1.09
The cardiovascular acitivity of ICI 118,587 a novel beta-adrenoceptor partial agonist [proceedings]. Br J Pharmacol (1979) 1.09
Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer. Br J Cancer (2009) 1.08
Incidence of subclinical metastasis in stage I and II ovarian carcinoma. Obstet Gynecol (1978) 1.07
Mutations in BRCA1 from fixed, paraffin-embedded tissue can be artifacts of preservation. Cancer Genet Cytogenet (1998) 1.06
Medroxyprogesterone acetate (Depo-Provera) vs. hydroxyprogesterone caproate (Delalutin) in women with metastatic endometrial adenocarcinoma. Cancer (1980) 1.03
Localisation of the breast-ovarian cancer susceptibility gene (BRCA1) on 17q12-21 to an interval of < or = 1 cM. Genes Chromosomes Cancer (1994) 1.02
Inhibition of deoxynucleotide-polymerizing enzyme activities of human cells and of simian sarcoma virus by heparin. Cancer Res (1978) 1.00
Estradiol production after ovariectomy for carcinoma of the breast. N Engl J Med (1969) 0.99
Preliminary trial of aminoglutethimide in breast cancer. Cancer (1973) 0.99
Alterations of O-glycan biosynthesis in human colon cancer tissues. Glycobiology (1994) 0.98
A novel series of potent and selective agonists at the opioid kappa-receptor. Eur J Pharmacol (1988) 0.97
Ovarian carcinoma in situ with germline BRCA1 mutation and loss of heterozygosity at BRCA1 and TP53. J Natl Cancer Inst (2000) 0.95
Fucosylation of disaccharide precursors of sialyl LewisX inhibit selectin-mediated cell adhesion. J Biol Chem (1997) 0.95
Selectin inhibition: synthesis and evaluation of novel sialylated, sulfated and fucosylated oligosaccharides, including the major capping group of GlyCAM-1. Glycobiology (1997) 0.94
Characterization of sialyloligosaccharide binding by recombinant soluble and native cell-associated CD22. Evidence for a minimal structural recognition motif and the potential importance of multisite binding. J Biol Chem (1995) 0.94
Comparative study of ovarian cancer histopathology by registry pathologists and referral pathologists: a study by the Gilda Radner Familial Ovarian Cancer Registry. Gynecol Oncol (2000) 0.93
Isolation and characterization of amaranthin, a lectin present in the seeds of Amaranthus caudatus, that recognizes the T- (or cryptic T)-antigen. J Biol Chem (1989) 0.92
Mucin synthesis. UDP-GlcNAc:GalNAc-R beta 3-N-acetylglucosaminyltransferase and UDP-GlcNAc:GlcNAc beta 1-3GalNAc-R (GlcNAc to GalNAc) beta 6-N-acetylglucosaminyltransferase from pig and rat colon mucosa. Biochemistry (1985) 0.92
Immunologic studies of human serous cystadenocarcinoma of ovary. Demonstration of tumor-associated antigens. Cancer (1973) 0.92
Squamous cell carcinoma arising in ovarian endometriosis. Gynecol Oncol (1978) 0.91
Tumor markers for ovarian cancer. Int Adv Surg Oncol (1979) 0.90
Adriamycin and bleomycin, alone and in combination, in gynecologic cancers. Cancer (1973) 0.90
Human splenic galaptin: carbohydrate-binding specificity and characterization of the combining site. Biochemistry (1990) 0.89
Control of O-glycan synthesis: specificity and inhibition of O-glycan core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 3-galactosyltransferase from rat liver. Biochem Cell Biol (1992) 0.89
Identification of a mutation in the structural alpha-L-fucosidase gene in fucosidosis. Am J Hum Genet (1988) 0.89
Five-year survival (with no evidence of disease) in patients with biopsy-confirmed aortic node metastasis from cervical carcinoma. Am J Obstet Gynecol (1981) 0.89
The presence of CA19-9 in serum and saliva from Lewis blood-group negative cancer patients. Jpn J Cancer Res (1988) 0.89
Microsatellite instability in ovarian and other pelvic carcinomas. Cancer Genet Cytogenet (2000) 0.88
Cell surface n-acetylneuraminic acid alpha2,3-galactoside-dependent intercellular adhesion of human colon cancer cells. Biochem Biophys Res Commun (1999) 0.88
Inhibition of human HT-29 colon carcinoma cell adhesion by a 4-fluoro-glucosamine analogue. Glycoconj J (1996) 0.87
Uridine 5'-diphosphate-galactose:glycoprotein galactosyltransferase activity in the ovarian cancer patient. Cancer Res (1976) 0.87
A comparison of the binding specificities of lectins from Ulex europaeus and Lotus tetragonolobus. Immunol Commun (1977) 0.87
Hydroxyurea: a radiation potentiator in carcinoma of the uterine cervix. A randomized double-blind study. Am J Obstet Gynecol (1983) 0.87
Variations in retention performance during long term memory formation. Nature (1971) 0.87
Paraaortic lymph node evaluation in stage I endometrial carcinoma. Obstet Gynecol (1982) 0.86
Mucin synthesis. Conversion of R1-beta 1-3Gal-R2 to R1-beta 1-3(GlcNAc beta 1-6)Gal-R2 and of R1-beta 1-3GalNAc-R2 to R1-beta 1-3(GlcNAc beta 1-6)GalNAc-R2 by a beta 6-N-acetylglucosaminyltransferase in pig gastric mucosa. Eur J Biochem (1986) 0.86
Glycosyltransferase and glycosidase activities in ovarian cancer patients. Cancer Res (1979) 0.85
Structure-activity relationship, selectivity and mode of inhibition of terminal deoxyribonucleotidyltransferase by streptolydigin analogs. Biochem Pharmacol (1980) 0.85
Hydroxyurea as a radiation sensitizer in women with carcinoma of the uterine cervix. Am J Obstet Gynecol (1977) 0.85
Estrogen secretion, biosynthesis and metabolism: their relationship to the menstrual cycle. Steroids (1966) 0.85
Weekly cis-diamminedichloroplatinum II as induction chemotherapy in recurrent carcinoma of the cervix. Gynecol Oncol (1984) 0.85
Aberrant alpha 1-->2fucosyltransferases found in human colorectal carcinoma involved in the accumulation of Leb and Y antigens in colorectal tumors. Jpn J Cancer Res (1993) 0.85
Expression of the p53 induced tumor suppressor p21waf1/cip1 in ovarian carcinomas: correlation with p53 and Ki-67 immunohistochemistry. Int J Gynecol Pathol (1997) 0.85
Purification and properties of an N-acetylglucosamine-specific lectin from Psathyrella velutina mushroom. J Biol Chem (1989) 0.85
Selective inhibition of terminal deoxynucleotidyl transferase from leukemic cells by streptolydigin. Biochem Biophys Res Commun (1976) 0.85
In vivo observations on testosterone and estradiol-17 beta protein binding in women. J Clin Endocrinol Metab (1969) 0.85
Cell surface receptors for lymphokines. II. Studies on the carbohydrate composition of the MIF receptor on macrophages using synthetic saccharides and plant lectins. Cell Immunol (1979) 0.85
High dose irradiation to biopsy confirmed aortic node metastases from carcinoma of the uterine cervix. Cancer (1977) 0.85
Total synthesis of sialylated and sulfated oligosaccharide chains from respiratory mucins. Chemistry (2000) 0.84
Mucin synthesis. II. Substrate specificity and product identification studies on canine submaxillary gland UDP-GlcNAc:Gal beta 1-3GalNAc(GlcNAc leads to GalNAc) beta 6-N-acetylglucosaminyltransferase. J Biol Chem (1980) 0.84
Cancer-associated elevation of alpha(1----3)-L-fucosyltransferase activity in human serum. Cancer (1988) 0.84
Parallel changes in the blood levels of abnormally-fucosylated haptoglobin and alpha 1,3 fucosyltransferase in relationship to tumour burden: more evidence for a disturbance of fucose metabolism in cancer. Cancer Lett (1992) 0.84
Genetic and enzymatic evidence for Lewis enzyme expression in Lewis-negative cancer patients. Cancer Res (1995) 0.83
Glycosidases of Aspergillus niger. IV. Purification and characterization of -mannosidase. J Biol Chem (1972) 0.83
Glycosidases of Aspergillus niger. 3. Purification and characterization of 1,2- -mannosidase. J Biol Chem (1972) 0.83
Binding of synthetic sulfated ligands by human splenic galectin 1, a beta-galactoside-binding lectin. Glycoconj J (1998) 0.83
Elevated activity of cytidine 5'-monophospho-N-acetylneuraminic acid hydrolase in serum of ovarian cancer patients as a possible indicator of malignancy. Biochem Biophys Res Commun (1978) 0.82
Tumor-related elevation of serum (alpha 1----3)-L-fucosyltransferase activity in gastric cancer. J Cancer Res Clin Oncol (1989) 0.82
Single agent vs combination chemotherapy in the treatment of ovarian cancer. Obstet Gynecol (1977) 0.81
Mutation analysis of BRCA1, TP53, and KRAS2 in ovarian and related pelvic tumors. Cancer Genet Cytogenet (1999) 0.81
Substrate specificity and inhibition of UDP-GlcNAc:GlcNAc beta 1-2Man alpha 1-6R beta 1,6-N-acetylglucosaminyltransferase V using synthetic substrate analogues. Glycoconj J (1995) 0.81
Para-aortic lymph node irradiation for carcinoma of the uterine cervix using split course technique. Gynecol Oncol (1975) 0.81
Inhibition of anti-Gal IgG binding to porcine endothelial cells by synthetic oligosaccharides. Transplantation (1996) 0.81
Primary ovarian dysgerminoma in a patient with a germline BRCA1 mutation. Int J Gynecol Pathol (2000) 0.81
Profile and possible origin of an adrenocortical carcinoma. J Clin Endocrinol Metab (1971) 0.81
Ovarian cancer alpha 1,3-L-fucosyltransferase. Differentiation of distinct catalytic species with the unique substrate, 3'-sulfo-N-acetyllactosamine in conjunction with other synthetic acceptors. J Biol Chem (1992) 0.81
Tumor-associated antigen(s) from granulosa cell carcinomas of the ovary. Cancer Res (1974) 0.81
A new method for assaying adhesion of cancer cells to the greater omentum and its application for evaluating anti-adhesion activities of chemically synthesized oligosaccharides. Clin Exp Metastasis (2000) 0.81
A missense mutation (S63L) in alpha-L-fucosidase is responsible for fucosidosis in an Italian patient. Hum Mol Genet (1994) 0.81
Characterization of a novel mucin sulphotransferase activity synthesizing sulphated O-glycan core 1,3-sulphate-Gal beta 1-3GalNAc alpha-R. Glycobiology (1995) 0.80
Elevated activities of blood group Le gene dependent alpha(1----3)-L-fucosyltransferase in human saliva of Lewis negative patients with epithelial ovarian cancer. Cancer Lett (1986) 0.80
An immunologic comparison between serous cystadenocarcinoma of the ovary and other human gynecologic tumors. Am J Obstet Gynecol (1973) 0.80
Synthesis of oligosaccharides containing the X-antigenic trisaccharide (alpha-L-Fucp-(1----3)-[beta-D-Galp-(1----4)]-beta-D-GlcpNAc) at their nonreducing ends. Carbohydr Res (1992) 0.80
Paget's disease of the vulva: a clinicopathologic study of eight cases. Obstet Gynecol (1975) 0.80
Survival after ovarian cancer induced intestinal obstruction. Gynecol Oncol (1982) 0.80
Comparative analysis of galactoside-binding lectins isolated from mammalian spleens. Arch Biochem Biophys (1987) 0.80
The labelling in vivo of nuclear and cytoplasmic RNA of pigeon reticulocytes. Biochim Biophys Acta (1968) 0.80
Binding of 4-methylumbelliferyl beta-D-galactosyl-(1 leads to 3)-N-acetyl-beta-D-galactosaminide to peanut agglutinin. Characterisation and application in substitution titrations. Eur J Biochem (1983) 0.80
Classification of IVS1-10T-->C as a polymorphism of BRCA1. Cancer Genet Cytogenet (1999) 0.80
Synthetic mucin fragments: methyl 3-O-(2-acetamido-2-deoxy-beta-D-galactopyranosyl-beta-D- 3-O-(2-acetamido-2-deoxy-3-O-beta-D-galactopyranosyl- beta-D-glucopyranosyl)-beta-D-galactoyranoside. pyranosyl)-beta-D-galactopyranoside. Carbohydr Res (1984) 0.79
Androgen and gonadotropin dynamics in testicular feminization syndrome. J Clin Endocrinol Metab (1972) 0.79